Attivio Accelerates Big Data Initiatives in Life Sciences

Today we announced an expanded relationship with PerkinElmer, a global leader focused on improving the health and safety of people and the environment, making them the exclusive OEM of Attivio licenses in the life sciences vertical. With this new partnership, PerkinElmer’s deep expertise across life science fields will be coupled with Attivio’s data discovery solutions, resulting in accelerated big data analysis projects.

Big Data Analytics for Life Sciences

Like other industries, life sciences grapples with finding the best ways to derive value from the massive volumes of data available to them. 

Big Data storage technology has become cheap and easy to use, but it’s not as easy to get data out of these storage systems, creating what many call “data swamps.”

Then you have the evolution of Business Intelligence tools, such as TIBCO Spotfire®, that offer strong reporting and dashboard capabilities to support better insights and decision-making on the data. These tools are only as good as the data you give them. Scientists and researchers spend disproportionate amounts of time just gathering data for analysis.   

A recent publication from another Attivio partner, PWC, highlights the impact of big data solutions, like those that Attivio and PerkinElmer now offer, for R&D groups in the pharmaceutical industry:

“Big data’s potential in pharmaceutical R&D is enormous. Armed with vast amounts of biological data and the tools to process it – cutting-edge analytics, streaming, massively parallel processing and domain-specific access and query technologies – the industry will be able to develop more effective, personalised medicines. It will also be able to shift the focus from reaction to prevention.” - PricewaterhouseCoopers report From vision to decision Pharma 2020

According to a report released by The IMS Institute for Healthcare Informatics, Riding the Information Technology Wave in Life Sciences: Priorities, Pitfalls and Promise, new capabilities are needed for life sciences companies to benefit from Big Data. The top 3 in the list reflect the challenge of finding and understanding data, in context.   

Launch of PerkinElmer Signals™ Perspectives

To solve these challenges, PerkinElmer announced the launch of PerkinElmer Signals™ Perspectives, powered by Attivio. This new solution enables unified access to all relevant data sources, structured and unstructured, internal and public, enabling scientists to make decisions based on all relevant information and accelerating the time to scientific and business insights.

Next Steps

At Attivio, we are particularly excited about this partnership, because it extends the availability of Attivio solutions in the Life Sciences vertical and it provides PerkinElmer the ability to help researchers and scientists transform productivity, so they can spend less time looking for data sources and more time developing data-driven insights. Accelerating research in life sciences is nothing short of game-changing.

For more information about this partnership:

Gartner Magic Quadrant for Insight Engines 2019
Attivio was recognized for our completeness in vision and ability to execute.